We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9072:TSENIKKON Holdings Co., Ltd. Analysis

Data as of 2026-08-02 - not real-time

¥5,043.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

NIKKON Holdings is trading just above a key support zone while sitting below its 20‑day moving average and still under the 50‑day average, indicating short‑term price weakness. The RSI has slipped into the oversold territory and the MACD remains in a bearish configuration, suggesting limited upside momentum in the next few weeks. Fundamentally, the company is delivering solid top‑line growth and a respectable dividend yield that appears sustainable given its cash flow generation. However, a DCF‑derived fair value is far below the current market price, flagging the stock as potentially overvalued.
With an 8‑plus percent revenue growth rate, modest profitability margins and a payout ratio under 50%, the dividend remains attractive. Yet the balance sheet shows a high debt‑to‑equity ratio and a modest return on equity, which together with a low beta but relatively high 30‑day volatility raise concerns about long‑term risk. Investors should weigh the near‑term bounce potential against the broader overvaluation and debt profile before committing.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering near a technical support level
  • RSI in oversold range suggesting limited upside
  • Stable dividend yield supporting cash‑flow appeal

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Consistent revenue growth but high debt‑to‑equity
  • Valuation above DCF fair value indicating limited upside
  • Sustainable dividend with moderate payout ratio

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Significant overvaluation relative to intrinsic estimate
  • Elevated leverage reducing financial flexibility
  • Modest ROE and ROA suggesting limited long‑term profitability

Key Metrics & Analysis

Financial Health

Revenue Growth8.80%
Profit Margin6.76%
P/E Ratio33.0
ROE7.46%
ROA3.44%
Debt/Equity56.38
P/B Ratio2.5
Op. Cash Flow¥38.2B
Free Cash Flow¥5.4B
Industry P/E30.9

Technical Analysis

TrendNeutral
RSI30.0
Support¥4,968.00
Resistance¥5,723.00
MA 20¥5,314.20
MA 50¥5,742.48
MA 200¥4,426.74
MACDBearish
VolumeStable
Fear & Greed Index92.88

Valuation

Fair Value¥14.43
Target Price¥4,400.00
Upside/Downside-12.75%
GradeOvervalued
TypeBlend
Dividend Yield2.22%

Risk Assessment

Beta0.14
Volatility33.31%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.